| Characteristic | Percentage of trials |
|---|---|
| Jazz Pharmaceuticals | 33.5% |
| New York State Psychiatric Institute | 8.4% |
| University of Colorado, Denver | 6.7% |
| University of California, San Diego | 6.1% |
| Yale University | 5% |
| Hadassah Medical Organization | 4.5% |
| Center for Medicinal Cannabis Research | 4.5% |
| NYU Langone Health | 3.9% |
| University of California, Los Angeles | 3.9% |
| Radboud University Medical Center | 3.4% |
| Pure Green | 3.4% |
| University of Florida | 2.8% |
| Wayne State University | 2.8% |
| University Health Network, Toronto | 2.8% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Sources
Release date
August 2023
More information
Region
Worldwide
Survey time period
January 1, 2010 to May 1, 2023
Number of respondents
149 trials
Supplementary notes
This statistic includes only sponsors with more than five trials sponsored. It only represents 149/439 trials. The vast majority (249/439) are sponsored by entities that have sponsored five trials or less.
Citation formats
